HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Ringwald Selected Research

Ranibizumab (Lucentis)

1/2017Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Ringwald Research Topics

Disease

1Macular Degeneration (Age-Related Maculopathy)
01/2017
1Retinal Vein Occlusion
01/2017
1Histoplasmosis
06/2010

Drug/Important Bio-Agent (IBA)

1Ranibizumab (Lucentis)FDA Link
01/2017
11-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2010

Therapy/Procedure

1Photochemotherapy (Photodynamic Therapy)
06/2010